NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr | ₹170 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹189 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹147 Cr |
| Mar2022 | ₹180 Cr |
| Mar2021 | ₹170 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹189 Cr | 55.02 | |
| Mar2024 | ₹122 Cr | -16.73 | |
| Mar2023 | ₹147 Cr | -18.42 | |
| Mar2022 | ₹180 Cr | 5.90 | |
| Mar2021 | ₹170 Cr | - | |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,686.3 Cr | -0.7% | -13.8% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -0.7% |
-13.8% |
-6.9% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses